Advertisement

Topics

Therachon AG Company Profile

18:32 EDT 20th April 2018 | BioPortfolio

Therachon is a clinical-stage global biotechnology company focused on developing medicines for rare diseases with significant unmet need. The company’s lead pipeline candidate, TA-46, is a novel protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism. Therachon is committed to translating the promise of its science into new treatments for patients with high unmet medical needs. For more information, visit www.therachon.com.


News Articles [4 Associated News Articles listed on BioPortfolio]

Therachon to Present at Cowen and Company 38th Annual Health Care Conference

Therachon AG, a clinical-stage biotechnology company focused on rare diseases, today announced Luca Santarelli, M.D., Chief Executive Officer, will present at the Cowen and Compan...

Therachon Appoints Industry Leader Aled Williams as Chief Commercial Officer and Head of Patient Access

Therachon AG, a clinical-stage biotechnology company focused on rare diseases, today announced it has appointed industry leader Aled Williams to the position of Chief Commercial O...

Therachon poaches Shire’s Aled Williams

He becomes the biotech’s chief commercial officer and head of patient access

Therachon Announces Dosing of First Subject in Phase 1 Clinical Trial Evaluating TA-46, a Novel Investigational Therapy for the Potential Treatment of Achondroplasia

Therachon AG, a biotechnology company focused on rare genetic diseases, today announced the dosing of the first subject in its Phase 1 trial for TA-46, a soluble recombinant human...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Therachon

Therachon is developing an innovative therapy for achondroplasia, the leading cause of dwarfism in humans. Therachon’s therapy aims to restore normal bone growth and proporti...

Therachon AG

Therachon is a clinical-stage global biotechnology company focused on developing medicines for rare diseases with significant unmet need. The company’s lead pipeline candidat...

More Information about "Therachon AG" on BioPortfolio

We have published hundreds of Therachon AG news stories on BioPortfolio along with dozens of Therachon AG Clinical Trials and PubMed Articles about Therachon AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Therachon AG Companies in our database. You can also find out about relevant Therachon AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record